atypical endometrial hyperplasia

Showing 1 - 16 of 16

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Atypical Endometrial Hyperplasia, Endometrial Carcinoma Stage I Trial in Peking (Medroxyprogesterone acetate + Atorvastatin)

Recruiting
  • Atypical Endometrial Hyperplasia
  • Endometrial Carcinoma Stage I
  • Medroxyprogesterone acetate + Atorvastatin
  • Peking, Beijing, China
    Wang Jianliu
Dec 29, 2022

Endometrial Carcinoma Stage I, Atypical Endometrial Hyperplasia Trial (No intervention)

Not yet recruiting
  • Endometrial Carcinoma Stage I
  • Atypical Endometrial Hyperplasia
  • No intervention
  • (no location specified)
Dec 3, 2022

CA-IX, p16, Proliferative Markers, and HPV in Diagnosing

Active, not recruiting
  • Atypical Endometrial Hyperplasia
  • +2 more
  • Cytology Specimen Collection Procedure
  • Laboratory Biomarker Analysis
  • Tucson, Arizona
  • +162 more
Oct 27, 2022

Atypical Endometrial Hyperplasia, Endometrial Carcinoma Trial in Duarte (Megestrol Acetate, Pterostilbene)

Recruiting
  • Atypical Endometrial Hyperplasia
  • Endometrial Carcinoma
  • Megestrol Acetate
  • Pterostilbene
  • Duarte, California
    City of Hope Medical Center
Oct 12, 2022

Endometrial Tumors, Atypical Endometrial Hyperplasia, Progesterone Resistance Trial in Shanghai (GnRHa, Letrozole 2.5mg,

Recruiting
  • Endometrial Neoplasms
  • +2 more
  • Shanghai, Shanghai, China
    Obstetrics and Gynecology Hospital, Fudan University
Jul 29, 2022

Atypical Endometrial Hyperplasia, Fertility Issues, Overweight and Obesity Trial in Shanghai (Intensive Lifestyle Intervention

Recruiting
  • Atypical Endometrial Hyperplasia
  • +2 more
  • Intensive Lifestyle Intervention (ILI)
  • +2 more
  • Shanghai, China
    Obstetrics and Gynecology Hospital of Fudan University
Jun 17, 2022

Atypical Endometrial Hyperplasia, FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma, FIGO Grade 2 Endometrial Endometrioid

Recruiting
  • Atypical Endometrial Hyperplasia
  • +2 more
  • Greeley, Colorado
  • +17 more
Jun 13, 2022

Atypical Endometrial Hyperplasia Trial in Shanghai (Metformin plus Megestrol acetate, Megestrol Acetate)

Terminated
  • Atypical Endometrial Hyperplasia
  • Metformin plus Megestrol acetate
  • Megestrol Acetate
  • Shanghai, Shanghai, China
    Obstetrics and Gynecology Hospital, Fudan University
Mar 24, 2022

Atypical Endometrial Hyperplasia, Obesity, Fertility Issues Trial in Shanghai (levonorgestrel-releasing intrauterine system,

Recruiting
  • Atypical Endometrial Hyperplasia
  • +2 more
  • levonorgestrel-releasing intrauterine system
  • Polyethylene Glycol Loxenatide
  • Shanghai, Shanghai, China
    Obstetrics & Gynecology Hospital of Fudan University
Jan 14, 2022

Endometrial Cancer, Atypical Endometrial Hyperplasia Trial in Chengdu (Progesterone, Mirena®, GnRH agonist)

Recruiting
  • Endometrial Cancer
  • Atypical Endometrial Hyperplasia
  • Chengdu, Sichuan, China
    West China Second University Hospital
Sep 3, 2021

Atypical Endometrial Hyperplasia Trial in Shanghai (Megestrol Acetate, Rosuvastatin)

Recruiting
  • Atypical Endometrial Hyperplasia
  • Shanghai, China
    Obstetrics and Gynecology Hospital, Fudan University
Aug 17, 2021

Atypical Endometrial Hyperplasia, Obese, Fertility Issues Trial (Liraglutide Injection, Megestrol Acetate 160 MG)

Withdrawn
  • Atypical Endometrial Hyperplasia
  • +2 more
  • Liraglutide Injection
  • Megestrol Acetate 160 MG
  • (no location specified)
Mar 23, 2021

Atypical Endometrial Hyperplasia Trial in Shanghai (Megestrol Acetate, Levonorgestrel-releasing Intrauterine System(LNG-IUS))

Completed
  • Atypical Endometrial Hyperplasia
  • Megestrol Acetate
  • Levonorgestrel-releasing Intrauterine System(LNG-IUS)
  • Shanghai, Shanghai, China
    Obstetrics and Gynecology Hospital, Fudan University
Jun 18, 2020

Atypical Endometrial Hyperplasia, Endometrial Carcinoma Trial in New York (Megestrol Acetate)

Completed
  • Atypical Endometrial Hyperplasia
  • Endometrial Carcinoma
  • Megestrol Acetate
  • New York, New York
  • +1 more
Mar 6, 2018

Atypical Endometrial Hyperplasia, Endometrial Adenocarcinoma, Recurrent Endometrial Carcinoma Trial (drug, device, other)

Withdrawn
  • Atypical Endometrial Hyperplasia
  • +10 more
  • megestrol acetate
  • +3 more
  • (no location specified)
Sep 9, 2014

Atypical Endometrial Polyps, Atypical Endometrial Hyperplasia Trial in Trieste (Levonorgestrel intrauterine device (IUD))

Completed
  • Atypical Endometrial Polyps
  • Atypical Endometrial Hyperplasia
  • Levonorgestrel intrauterine device (IUD)
  • Trieste, Friuli Venezia Giulia, Italy
    Institute of Child Health, IRCCS Burlo Garofolo
Sep 1, 2011